Boehringer and Gubra partner to develop food intake regulators

Boehringer Ingelheim GmbH (Ingelheim, Germany) partnered with Gubra ApS (Horsholm, Denmark) to jointly identify and develop peptides that are "able to regulate food intake." Gubra will perform in vivo testing of candidates, and Boehringer will further develop the compounds. Boehringer said it is aiming to move a program into the clinic in three years...